RX PRODUCTS
Since 1990, Stragen has always been committed to the development of Selected and Advanced Generics
As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we constantly aim at improving the existing therapeutics by offering:
- Niche molecules
- Hard-to-make drugs
- Innovative delivery forms to improve health daily practices
ORAL
We specialize in the development and production management of complex low-concentration hormonal products, niche modified release drugs, and conventional release solid dosage forms.
PARENTERAL
We develop and manage the manufacturing of high-quality parenteral drugs, such as antibiotics (including Penicillin, Cephalosporin and Macrolide) and highly potent cytostatic agents.
TOPICAL
We offer expertise in the development and production of specialized gels and creams within the anti-inflammatory and retinoid therapeutics classes.
Pharmaceutical forms
Therapeutic Areas
Cyproterone acetate
50 mg
Diosmin
600 mg
Cyproterone acetate / Ethinylestradiol
2 mg/0.035 mg
Desogestrel
75 μg
Desogestrel / Ethinylestradiol
150 μg/20 μg
150 μg/30 μg
Dienogest
2 mg
Drospirenone / Ethinylestradiol
3 mg/0.03 mg
Gestodene / Ethinylestradiol
75 μg/20 μg
75 μg/30 μg
Gestodene / Ethinylestradiol
60 μg/15 μg
Nomegestrol acetate
5 mg
Cyproterone acetate
50 mg
100 mg
Urapidil
30 mg
60 mg
90 mg
Cefepime
1 g
2 g
Cefotaxime
0.5 g
1 g
2 g
Ceftazidime
1 g
2 g
3 g
6 g
Ceftriaxone
250 mg
500 mg
1 g
2 g
10 g
Cefuroxime
250 mg
750 mg
1.5 g
Cloxacillin
500 mg
1 g
2 g
10 g
Erythromycin
1 g
Flucloxacillin
1 g
2 g
4 g
Piperacillin / Tazobactam
2 g/250 mg
3 g/375 mg
4 g/500 mg
12 g/1.5 g
36 g/4.5 g
Atosiban
7.5 mg/ml
Tranexamic Acid
100 mg/ml
Levetiracetam
5 mg/ml
10 mg/ml
15 mg/ml
Amiodarone
50 mg/ml
Milrinone
1 mg/ml
Urapidil
5 mg/ml
Diclofenac
1%
Adapalene
1 mg/g